Product
Supplier
Encyclopedia
Inquiry
Enclomiphene citrate high quality buy - large image1
Enclomiphene citrate high quality buy - image1
Enclomiphene citrate high quality buy - image2
Enclomiphene citrate high quality buy - image3

Enclomiphene citrate high quality

115 Inquiries

Unit Price:

$1/UNIT FOB

Get Latest Price
CAS No.:

7599-79-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

cn

Packaging:

foil bag

Price valid (until):

2026-11-10

Company Type:
Manufactory
Location:
China
Payment Terms:
L/C,100% TT in advance
Average Lead Time:
3 days
Qualification:
Main Products:

Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Enclomiphene citrate exhibits anti-estrogenic effects and is primarily used to treat polycystic ovary syndrome; it may also be used to treat other conditions associated with ovarian dysfunction, such as dysfunctional uterine bleeding and menstrual irregularities.

    ECHEMI Editorial Reference
    Enclomiphene citrate is a potent and orally active oestrogen receptor antagonist, with antioestrogenic property[1].

    Basic Info
    Product Name:

    Enclomiphene citrate

    Other Name:

    Ethanamine,2-[4-[(1E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethyl-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);Triethylamine,2-[p-(2-chloro-1,2-diphenylvinyl)phenoxy]-,citrate (1:1),(E)-;Ethanamine,2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethyl-,(E)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);trans-Clomiphene citrate;Clomiphene B citrate;Enclomid;(E)-Clomiphene citrate;Enclomiphene citrate;Androxal;EnCyzix;96189-17-2;207562-80-9

    CAS No.:

    7599-79-3

    Molecular Formula:

    C26H28ClNO.C6H8O7

    InChIKeys:

    InChIKey=PYTMYKVIJXPNBD-BTKVJIOYSA-N

    Molecular Weight:

    598.08300

    Exact Mass:

    597.21300

    EC Number:

    200-035-3

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    144.60000

    XLogP3:

    5.31410

    Boiling Point:

    509ºC at 760mmHg

    Flash Point:

    261.6ºC

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

    Location:

    Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China

    Payment Terms:

    L/C,100% TT in advance

    Average lead Time:

    3 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2012

    Company Certificates
    • Jinan Million Pharmaceutical Co., Ltdbusiness license business license

    Founded in 2012, Jinan Million Pharmaceutical Co., Ltd (Jinan Milin Pharmaceutical Co., Ltd) is a modern pharmaceutical enterprise guided by innovation. Million pharm has excellent research and development capabilities and complete industrial bases with international quality management system. It is dedicated to the research, development, production and customization of pharmaceuticals and advanced pharmaceutical intermediates.
     
    Jinan Million Pharmaceutical Co., Ltd has been focusing on the research of Cerebro-cardiovascular drugs, Central nervous system drugs, Anti-cancer drugs, Antibacterial drugs and others for 12 years; the products are: Apixaban, Lurasidone, Bexagliflozin, Votioxitine, Loxo-292/Selpercatinib, Baricitinib and intermediates. Million has worked with reputable customers, like METROCHEM API PVT LTD; BDR LIFESCIENCES PVT.LTD; INCETPAT PHARM; SRINI CHEM; EVA PHARMA; PHARMAFFILIATES ANALYTICS & SYNTHETICS (P) LTD; ....from India, Egypt, Canada...



    Jinan Million Pharmaceutical Co., Ltd has a 1,500㎡ R&D center in the Zhongguancun E Valley (Qihe) Incubator, equipped with complete test equipment, such as high-performance liquid chromatography, nuclear magnetic resonance spectrometer, liquid chromatography mass spectrometer, automatic polarimeter, etc., which can meet the needs of various  laboratory scale tests in different conditions. The pilot workshop is equipped with 50L and 100L glass reactors, high and low temperature equipment, etc., which can support organic chemical reactions at -100°C or 200°C. In addition, Million has a production site in Linyi city with many independent production lines, such as: production line of Apixabn intermediate 20 tons/year, production line of Lurasidon intermediate 10 tons/year, which can meet the commercial production of various products.
     
    The technical team is composed of high-level talents in major of pharmacy, bio-pharmaceutical or chemical synthesis, of which 10% has doctor’s degree and 15% has master’s degree. The team members are young and energetic with innovative spirit and willing to overcome obstacles.
     
    Jinan Million Pharmaceutical Co., Ltd adheres to the business philosophy of "dedication and innovation", insists on pioneering and innovating, constantly improves the quality system, and vigorously trains technical and management talents to build an elite team and serves customers better. Looking forward to cooperate with you for joint development and common progress.

  • Inquiry History
    115 Inquiries
    Country Product Purchase Quantity Date Posted
    Poland

    7599-79-3

    50 G May 14, 2025
    United States

    Cas No. 7599-79-3

    10 G Mar 9, 2025
    United States

    Factory Supply Best Price Pure 99% Enclomiphene Citrate Powder CAS 7599-79-3

    10 G Mar 3, 2026
    United Kingdom

    Enclomiphene citrate 99.7% CAS 7599-79-3

    5 G Jun 11, 2024
    New Zealand

    Clomiphene citrate 98% Powder 7599-79-3 Senwayer

    1 MT Nov 15, 2023
    Malaysia

    High purity Enclomiphene citrate 99.7% kuohuai cas 7599-79-3

    50 G Oct 25, 2023
    United Kingdom

    Factory Supply High Quality Enclomiphene citrate 99.7% CAS 7599-79-3

    0.1 KG Jun 4, 2024
    United States

    CAS 7599-79-3 Enclomiphene citrate USP PHARMACY GRADE

    10 G Feb 19, 2025
    United Kingdom

    Bulk Sale Enclomiphene citrate 99% Powder 7599-79-3

    1 MT Nov 5, 2023
    United States

    high quality pharmacy grade API Enclomiphene Citrate Powder 99% purity with good price CAS 7599-79-3

    100 G Feb 27, 2026
    United States

    Enclomiphene citrate CAS 7599-79-3 99% Pharma grade China factory supply directly

    1 KG Jun 11, 2026
    United States

    Enclomiphene Citrate

    100 G Aug 17, 2026
    United Kingdom

    Enclomaphine

    1 G Dec 26, 2024
    India

    Enclomiphene Citrate

    10 G Mar 24, 2026
    Russia

    Enclomiphene

    100.00 G Aug 14, 2024
    United States

    Enclomiphene citrate

    5 G Oct 5, 2026
    Germany

    Enclomiphene citrate

    50 G Oct 4, 2026
    Canada

    Enclomiphene citrate

    100 G Aug 10, 2026
    Peru

    Enclomiphene Citrate

    100 MG Jun 18, 2026
    United States

    ENCLOMIPHENE CITRATE

    50 G Jun 16, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.